Recent drug approvals for acute myeloid leukemia

by Catherine Lai, Kimberley Doucette, Kelly Norsworthy
Published 2019-09-01

Advances in therapeutic options for newly diagnosed, high-risk AML patients

by Kimberley Doucette, Judith Karp, Catherine Lai
Published 2021-05-01

Technical Advances in the Measurement of Residual Disease in Acute Myeloid Leukemia

by Gregory W. Roloff, Catherine Lai, Christopher S. Hourigan, Laura W. Dillon
Published 2017-09-01

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

by Bogdan Popescu, Sheenu Sheela, Julie Thompson, Sophia Grasmeder, Therese Intrater, Christin B. DeStefano, Christopher S. Hourigan, Catherine Lai
Published 2019-12-01

The Lothian Diary Project: Investigating the Impact of the COVID-19 Pandemic on Edinburgh and Lothian Residents

by Lauren Hall-Lew, Claire Cowie, Stephen Joseph McNulty, Nina Markl, Shan-Jan Sarah Liu, Catherine Lai, Clare Llewellyn, Beatrice Alex, Nini Fang, Zuzana Elliott, Anita Klingler
Published 2021-04-01

Successful salvage chemotherapy and allogeneic transplantation of an acute myeloid leukemia patient with disseminated Fusarium solani infection

by Sheenu Sheela, Sawa Ito, Jeffrey R. Strich, Maura Manion, Celina Montemayor-Garcia, Hao-Wei Wang, Karolyn A. Oetjen, Kamile A. West, Austin J. Barrett, Mark Parta, Juan Gea-Banacloche, Steven M. Holland, Christopher S. Hourigan, Catherine Lai
Published 2017-01-01

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

by Hong Yuen Wong, Anthony D. Sung, Katherine E. Lindblad, Sheenu Sheela, Gregory W. Roloff, David Rizzieri, Meghali Goswami, Matthew P. Mulé, Nestor R. Ramos, Jingrong Tang, Julie Thompson, Christin B. DeStefano, Kristi Romero, Laura W. Dillon, Dong-Yun Kim, Catherine Lai, Christopher S. Hourigan
Published 2019-01-01